Outcomes of the Childhood Asthma Prevention Study at 11.5 years - 30/10/13
Doi : 10.1016/j.jaci.2013.06.005
Brett G. Toelle, PhD a, b 
, Frances L. Garden, MBiostat a, b, Kitty K.W. Ng, MPH(Hons) a, Elena G. Belousova, MSc(AppMath) a, Catarina Almqvist, PhD a, c, Chris T. Cowell, PhD b, d, Euan R. Tovey, PhD a, b, Karen L. Webb, PhD e, Stephen R. Leeder, PhD b, Guy B. Marks, PhD a, b
for the
, Frances L. Garden, MBiostat a, b, Kitty K.W. Ng, MPH(Hons) a, Elena G. Belousova, MSc(AppMath) a, Catarina Almqvist, PhD a, c, Chris T. Cowell, PhD b, d, Euan R. Tovey, PhD a, b, Karen L. Webb, PhD e, Stephen R. Leeder, PhD b, Guy B. Marks, PhD a, bfor the
Childhood Asthma Prevention Study Team
aWoolcock Institute of Medical Research, Sydney, Australia
b University of Sydney, Sydney, Australia
c Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
d The Children's Hospital at Westmead, Westmead, Australia
e Atkins Center for Weight and Health, University of California at Berkeley, Berkeley, Calif
| This study was funded by the National Health and Medical Research Council of Australia, the Cooperative Research Centre for Asthma, the New South Wales Department of Health, Children's Hospital Westmead, and University of Sydney, Faculty of Medicine, Strategic Research Grant 2008. C.A. was funded by the Swedish Heart Lung Foundation and Swedish Society of Medicine. Contributions of goods and services were made by Allergopharma Joachim Ganzer KG Germany, John Sands Australia, Hasbro, Toll Refrigerated, AstraZeneca Australia, and Nu-Mega Ingredients Pty Ltd. Goods were provided at reduced cost by Auspharm, Allersearch, and Goodman Fielder Foods. |
|
| Disclosure of potential conflict of interest: G. B. Marks is a board member for Novartis, has received one or more grants from or has one or more grants pending with AstraZeneca, and has received one or more payments for the development of educational presentations for GlaxoSmithKline and AstraZeneca. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 132 - N° 5
P. 1220 - novembre 2013 Regresar al número
Artículo precedente
- Use of ondansetron for food protein–induced enterocolitis syndrome
- Teri Holbrook, Corinne A. Keet, Pamela A. Frischmeyer-Guerrerio, Robert A. Wood
- Age-stratified comparison of large and peripheral airway/alveolar nitric oxide levels in children and young adults
- Arthur F. Gelb, Deepak H. Singh, Roxanna Moridzadeh, Christine Fraser, Diem Tran, Sylvia Verbanck, Steven C. George
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?